Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

NCT04708834 is registered in ClinicalTrials.gov with Biohaven Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04708834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Lead sponsor
Biohaven Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 30, 2021
Completion date
February 13, 2026
Enrollment
772 (actual)
Sites
175

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive compulsive disorder